Can a simple device keep blood flowing and prevent dangerous clots?

NCT ID NCT05469282

Completed Disease control Sponsor: Ceragem Clinical Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed trial tested a device called Ceragem Master V6 to see if it improves blood circulation in people at risk for deep vein thrombosis (DVT) and in healthy adults. 59 participants used the device once, and researchers measured changes in blood flow speed and vein size using ultrasound. The goal was to see if the device could help prevent blood clots by improving circulation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ceragem Master V6 (blood circulation device)
What this could lead to: If it works, this device could help improve blood flow and reduce the risk of deep vein thrombosis (DVT) in people at risk.
What could go wrong: This is a small, early-stage trial with only 59 participants and no comparison group, so results may not apply widely. The device is already on the market, so the benefit over standard care is unclear.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD CIRCULATION DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

vascular disorder venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLOOD CIRCULATION DISORDER DEEP VEIN THROMBOSIS

Contacts and locations

Locations

Presbyterian Medical Center

Jeonju, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.